Page last updated: 2024-09-02

landiolol and dobutamine

landiolol has been researched along with dobutamine in 4 studies

Compound Research Comparison

Studies
(landiolol)
Trials
(landiolol)
Recent Studies (post-2010)
(landiolol)
Studies
(dobutamine)
Trials
(dobutamine)
Recent Studies (post-2010) (dobutamine)
311851766,3578181,011

Protein Interaction Comparison

ProteinTaxonomylandiolol (IC50)dobutamine (IC50)
Solute carrier family 22 member 1 Homo sapiens (human)4.17
Epidermal growth factor receptorHomo sapiens (human)5.551
Tyrosine-protein kinase LckHomo sapiens (human)5.519
Tyrosine-protein kinase FynHomo sapiens (human)3.975
Beta-2 adrenergic receptorHomo sapiens (human)1.517
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)0.383
Beta-1 adrenergic receptorHomo sapiens (human)1.944
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)0.599
Alpha-2B adrenergic receptorHomo sapiens (human)2.966
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.383
Alpha-1D adrenergic receptorHomo sapiens (human)0.114
Sodium-dependent serotonin transporterHomo sapiens (human)1.895
D(3) dopamine receptorHomo sapiens (human)4.985
Sodium-dependent dopamine transporter Homo sapiens (human)0.155
Sigma non-opioid intracellular receptor 1Homo sapiens (human)2.518

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's3 (75.00)2.80

Authors

AuthorsStudies
Kawashima, S; Kurita, T; Morita, K; Nakajima, Y1
Hodisch, J; Kadlecová, P; Krumpl, G; Trebs, M; Ulč, I1
Hodisch, J; Husch, B; Kadlecová, P; Krumpl, G; Trebs, M; Ulč, I1
Ishii, T; Izawa, K; Kinoshita, M; Masuda, M; Onoda, T; Sato, N; Tanaka, H; Urano, A1

Trials

2 trial(s) available for landiolol and dobutamine

ArticleYear
Pharmacodynamic and pharmacokinetic behavior of landiolol during dobutamine challenge in healthy adults.
    BMC pharmacology & toxicology, 2020, 11-25, Volume: 21, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiotonic Agents; Cross-Over Studies; Dobutamine; Double-Blind Method; Female; Healthy Volunteers; Heart Rate; Humans; Infusions, Intravenous; Male; Morpholines; Prospective Studies; Urea; Young Adult

2020
Blood Pressure Recovery After Dobutamine Antagonism: Partial With Landiolol, None With Esmolol.
    Clinical pharmacology in drug development, 2022, Volume: 11, Issue:3

    Topics: Blood Pressure; Cross-Over Studies; Dobutamine; Humans; Morpholines; Propanolamines; Prospective Studies; Urea

2022

Other Studies

2 other study(ies) available for landiolol and dobutamine

ArticleYear
Dobutamine, a β1 Adrenoceptor Agonist, Increases Cerebral Oxygenation During Acute Anemia and Apneic Hypoxia.
    Neurocritical care, 2017, Volume: 27, Issue:3

    Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Apnea; Cerebrum; Disease Models, Animal; Dobutamine; Hypoxia; Morpholines; Oxygen Consumption; Spectroscopy, Near-Infrared; Swine; Urea

2017
[Chemical Stability after Mixing Continuous Infusion Drugs Used to Treat Cardiogenic Shock].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2022, Volume: 142, Issue:11

    Topics: Dobutamine; Humans; Milrinone; Norepinephrine; Pharmaceutical Preparations; Shock, Cardiogenic

2022